Cargando…
A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance
Multidrug resistance (MDR) to chemotherapeutic drugs remains one of the major impediments to the treatment of cancer. Discovery and development of drugs that can prevent and reverse the acquisition of multidrug resistance constitute a foremost challenge in cancer therapeutics. In this work, we scree...
Autores principales: | Zahra, Rida, Furqan, Muhammad, Ullah, Rahim, Mithani, Aziz, Saleem, Rahman Shah Zaib, Faisal, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266297/ https://www.ncbi.nlm.nih.gov/pubmed/32484843 http://dx.doi.org/10.1371/journal.pone.0233993 |
Ejemplares similares
-
Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
por: Manzoor, Safia, et al.
Publicado: (2018) -
Author Correction: Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
por: Manzoor, Safia, et al.
Publicado: (2018) -
Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
por: Wang, Gangyang, et al.
Publicado: (2022) -
Interaction potential of Carmegliptin with P-glycoprotein (Pgp) transporter in healthy volunteers
por: Kuhlmann, Olaf, et al.
Publicado: (2014) -
Non-Nutritive Sweeteners Acesulfame Potassium and Sucralose Are Competitive Inhibitors of the Human P-glycoprotein/Multidrug Resistance Protein 1 (PGP/MDR1)
por: Danner, Laura, et al.
Publicado: (2023)